Knowledge at Wharton

Collusion over Drug Prices: Will Generic Manufacturers Pay?

4 snips
May 20, 2019
A lawsuit alleges collusion and price fixing among 20 generic drug makers, revealing the failure of competitive mechanisms. The prevalence and profitability of generic drugs in the US healthcare system is discussed, as well as the insurance industry's reaction and potential government involvement. The significance of low-priced drug companies in the complex pharmacy benefits managers (PBMs) market is also explored.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Collusion and Price Fixing in the Generic Drug Industry
01:31 • 15min
3
The Prevalence and Profitability of Generic Drugs in the US Healthcare System
16:26 • 3min
4
The Insurance Industry's Reaction and Government Involvement
19:10 • 3min
5
The Potential Impact of Low-Priced Drug Companies
22:13 • 2min